Pear’s Somryst precursor improved sleep health measures among patients with chronic insomnia and depressive symptoms

The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.

Leave a Reply

Your email address will not be published.